Kodiak Sciences (KOD) Change in Account Payables (2017 - 2026)
Kodiak Sciences (KOD) posted Change in Account Payables of -$733000.0 for Q1 2026, down 145.08% on a QoQ basis from $1.6 million in Q4 2025, and down 128.13% year-over-year from $2.6 million in Q1 2025.
Kodiak Sciences (KOD) Change in Account Payables (2017 - 2026) Analysis & Trends
Kodiak Sciences' Change in Account Payables history runs 10 years deep, the most recent figure standing at -$733000.0 for Q1 2026.
- Quarterly Change in Account Payables fell 128.13% year-over-year to -$733000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.7 million (up 17.22% YoY) and the FY2025 annual result came in at $8.1 million, up 183.26% from the prior year.
- Change in Account Payables was -$733000.0 for Q1 2026 at Kodiak Sciences, down from $1.6 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $6.5 million in Q1 2022 and bottomed at -$11.1 million in Q1 2024.
- A 5-year average of $288294.1 and a median of $637000.0 in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables soared 4042.42% — and 2024, when it sank 485.42%.
- Kodiak Sciences' Change in Account Payables stood at -$5.4 million in 2022, then soared by 145.74% to $2.5 million in 2023, then slumped by 74.35% to $637000.0 in 2024, then jumped by 155.26% to $1.6 million in 2025, then tumbled by 145.08% to -$733000.0 in 2026.
- Business Quant data shows KOD's Change in Account Payables at -$733000.0 in Q1 2026, $1.6 million in Q4 2025, and $5.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - | -733,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -733,000.00 |
| Mar 31, 2026 | -733,000.00 |
| Dec 31, 2025 | 1.63 Mn |
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | 5.32 Mn |
| Sep 30, 2025 | 5.32 Mn |
| Jun 30, 2025 | -1.48 Mn |
| Jun 30, 2025 | -1.48 Mn |
| Mar 31, 2025 | 2.61 Mn |
| Mar 31, 2025 | 2.61 Mn |
| Dec 31, 2024 | 637,000.00 |
| Dec 31, 2024 | 637,000.00 |
| Sep 30, 2024 | 1.58 Mn |
| Sep 30, 2024 | 1.58 Mn |
| Jun 30, 2024 | -791,000.00 |
| Jun 30, 2024 | -791,000.00 |
| Mar 31, 2024 | -11.12 Mn |
| Mar 31, 2024 | -11.12 Mn |
| Dec 31, 2023 | 2.48 Mn |
| Dec 31, 2023 | 2.48 Mn |